Axonics
USWho owns Axonics?
Axonics was owned by Edmond de Rothschild Private Equity (France) through Edmond de Rothschild Investment Partners BioDiscovery 4 (2015 vintage) from 2014 to 2024, exited via Trade Sale. Across its history, Axonics has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Key facts
- ·Fully exited in 2024.
- ·Average hold across 2 realized cycles: 8 years.
Ownership history
2 ownership periods · co-invest detected
More from Edmond de Rothschild Investment Partners BioDiscovery 4
Other portfolio companies in the same fund.
Finland
FranceMore Edmond de Rothschild Private Equity (France) portfolio companies
From the same investor, across funds.
UK
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Axonics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Axonics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in